Every recall we track for Camber Pharmaceuticals Inc. — 5 in all — plus the complaints and injury reports the public filed about them.
Camber Pharmaceuticals recalls Atovaquone Oral Suspension USP (750 mg/5 mL) due to Bacillus cereus contamination in repackaged product. This poses a risk of infection from improper use.
Camber Pharmaceuticals recalls Lacosamide Oral Solution due to p-Hydroxybenzoic Acid content failing excipient specifications. This affects prescription 200mL bottles manufactured in 2024. No remedy specified in official notice.